Lyell Immunopharma (LYEL) Stock Soars Following Private Placement Announcement
Summary by financialbuzz.com
1 Articles
1 Articles
Lyell Immunopharma (LYEL) Stock Soars Following Private Placement Announcement
Shares of Lyell Immunopharma Inc. (NASDAQ: LYEL) surged by 20% on Friday morning, driven by news of a substantial private placement financing deal worth up to $100 million, aimed at advancing its lead CAR T-cell therapy candidate, LYL314. The company disclosed that it has entered into agreements with institutional investors for the initial closing of approximately $50 million in common stock at a price of $13.32 per share, expected to finalize o…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium